CONNECTING Healthcare EXPERTISE

THE CLINICIAN EXCHANGE is a virtual exchange designed to pair specific clinical skillsets with specific industry initiatives.

EXCHANGE YOUR EXPERTISE

Learn how you can unlock the power of your expertise and experience to impact the healthcare industry in ways never before imagined

REGISTER NOWLEARN MORE

EXTEND, EXCEL…EXPLORE THE EXCHANGE

Learn how you can cost-effectively multiply your sales, education and R&D resources in an instant

REGISTER NOWLEARN MORE

COMMUNITY PORTAL

IN THE NEWS

CLINICIAN NEWS

Provided by: Medscape

Polypharmacy and Cognitive and Physical Capability

Published: Tue, 26 Jun 2018 12:00:00 EDT
This study examined associations between polypharmacy in older adults and detailed measures of physical and cognitive capability. Is there a cumulative, dose-dependent relationship?
Journal of the American Geriatrics Society

Dementia and Risk of 30-Day Readmission in Older Adults

Published: Tue, 19 Jun 2018 12:00:00 EDT
Do older patients with dementia have a higher risk of hospital readmission within 30 days after discharge? How does primary diagnosis impact this risk?
Journal of the American Geriatrics Society

Telemedicine vs. In-person Follow-up After Neurosurgery

Published: Mon, 18 Jun 2018 12:00:00 EDT
Are telemedicine consultations a cost-saving alternative for follow-up care after elective neurosurgical procedures?
Neurosurgical Focus
Displaying results 1-3 (of 20)
 1 - 2 - 3 - 4 - 5 - 6 - 7 

HEALTHCARE SUPPLIER NEWS

Chutes & Ladders—Alder poaches Juno executive for CEO

Published: Fri, 15 Jun 2018 13:58:23 +0000
Alder poaches Juno executive for CEO to prep for its migraine launch, Allergan brings in Abbott veteran after investors demand change, and ResTORbio hires Novartis researcher for clinical VP—these moves, plus more hirings, firings and retirings throughout the industry.

Bluebird preps E.U. filing for revamped thalassemia gene therapy

Published: Fri, 15 Jun 2018 13:10:46 +0000
With new data from a phase 1/2 trial of its LentiGlobin gene therapy in thalassemia in the bag, Bluebird Bio is pushing ahead with a European filing—and it could be that a follow-up in sickle cell disease is not too far behind.

GlaxoSmithKline's head of dermatology joins JAK developer Aclaris

Published: Fri, 15 Jun 2018 12:54:04 +0000
GlaxoSmithKline’s former head of dermatology R&D, David Gordon, has joined Aclaris Therapeutics as its new chief medical officer.
Displaying results 1-3 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 

HAVE A QUESTION?

 Security code
1-800-4-the-clinx

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy
Top